Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Axxima Pharmaceuticals AG

Division of Agennix Inc./GPC Biotech AG
www.axxima.com

Latest From Axxima Pharmaceuticals AG

German Biotech: Coalescing around the Haves

Positive signs are coming out of German biotech for the first time in years. Scientific output remains strong. The subsector boasts its first profitable pharmaceutical-oriented company; several on- or near-market products, and even a nascent IPO market. The fact that dozens of companies are expected to go bust this year is another sign of the industry's maturation. The long-awaited consolidation predicted in the wake of the Neuer Markt demise is seemingly finally happening. The have-nots are finally beginning to cluster around the haves.
BioPharmaceutical Strategy

U3 Pharma AG

German start-up U3 Pharma AG is hoping that its focus on, and understanding of, full biological systems rather than simply on chemistry will give it a chance to win the race to find new cancer drugs.
BioPharmaceutical Europe

European Biotechnology--A Question of Control

European biotech companies have only partnered a third of the development drugs in their collective pipelines. With product-hungry Big Pharma prepared to pay ever-higher prices to in-license, much of the European biotech industry is in a strong position.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • VirGene Pharmaceuticals AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Agennix Inc.
  • Senior Management
  • Ranier Wessel, Pres. & CEO
    Christian Wallasch, PhD, VP, Pre-Clinical Dev.
    Clive Krückemeyer , VP, Fin.
    Matthias Stein-Gerlach, PhD, VP, Bus. Dev.
  • Contact Info
  • Axxima Pharmaceuticals AG
    Phone: (49) 89 740 1650
    Am Klopferspitz 19
    Martinsried, 82152
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register